87 related articles for article (PubMed ID: 6230179)
21. Location of specific units in heparin and heparan sulfate.
Danishefsky I; Rosenfeld L; Kuhn L; Lahiri B; Whyzmuzis C
Ann N Y Acad Sci; 1989; 556():29-35. PubMed ID: 2525360
[No Abstract] [Full Text] [Related]
22. Plasma and urinary glycosaminoglycans in the course of juvenile idiopathic arthritis.
Winsz-Szczotka K; Kuźnik-Trocha K; Komosińska-Vassev K; Wisowski G; Gruenpeter A; Lachór-Motyka I; Żegleń B; Lemski W; Olczyk K
Biochem Biophys Res Commun; 2015 Mar; 458(3):639-643. PubMed ID: 25684189
[TBL] [Abstract][Full Text] [Related]
23. Analysis of glycosaminoglycan chains from different proteoglycan populations in human embryonic skin fibroblasts.
Schmidtchen A; Fransson LA
Eur J Biochem; 1992 Sep; 208(2):537-46. PubMed ID: 1521543
[TBL] [Abstract][Full Text] [Related]
24. Removal of sulfated (heparan sulfate) or nonsulfated (hyaluronic acid) glycosaminoglycans results in increased permeability of the glomerular basement membrane to 125I-bovine serum albumin.
Rosenzweig LJ; Kanwar YS
Lab Invest; 1982 Aug; 47(2):177-84. PubMed ID: 6213815
[No Abstract] [Full Text] [Related]
25. High-performance liquid chromatographic identification of disaccharides generated from heparan sulphate isomers using heparitinases.
Murata K; Yokoyama Y; Yoshida K
J Chromatogr; 1989 Nov; 496(1):27-38. PubMed ID: 2531752
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a platelet endoglycosidase degrading heparin-like polysaccharides.
Oldberg A; Heldin CH; Wasteson A; Busch C; Höök M
Biochemistry; 1980 Dec; 19(25):5755-62. PubMed ID: 7459342
[TBL] [Abstract][Full Text] [Related]
27. Compositional changes of urinary acidic glycosaminoglycans in progressive systemic sclerosis.
Murata K; Takeda M
Clin Chim Acta; 1980 Nov; 108(1):49-59. PubMed ID: 6778637
[TBL] [Abstract][Full Text] [Related]
28. Breaking down the barrier: evidence against a role for heparan sulfate in glomerular permselectivity.
Harvey SJ; Miner JH
J Am Soc Nephrol; 2007 Mar; 18(3):672-4. PubMed ID: 17301187
[No Abstract] [Full Text] [Related]
29. Selective removal of heparan sulfate chains from proteoheparan sulfate with a commercial preparation of heparitinase.
Kato M; Oike Y; Suzuki S; Kimata K
Anal Biochem; 1985 Aug; 148(2):479-84. PubMed ID: 2932976
[TBL] [Abstract][Full Text] [Related]
30. Heparin sequences in the heparan sulfate chains of an endothelial cell proteoglycan.
Nader HB; Dietrich CP; Buonassisi V; Colburn P
Proc Natl Acad Sci U S A; 1987 Jun; 84(11):3565-9. PubMed ID: 2954157
[TBL] [Abstract][Full Text] [Related]
31. Determination of hyaluronic acid, dermatan sulphate, heparan sulphate and chondroitin 4/6 sulphate in human dermis, and a material of reference.
Poulsen JH; Cramers MK
Scand J Clin Lab Invest; 1982 Nov; 42(7):545-9. PubMed ID: 6218602
[TBL] [Abstract][Full Text] [Related]
32. Circulating dermatan sulfate and heparan sulfate/heparin proteoglycans in children undergoing liver transplantation.
Mitchell L; Superina R; Delorme M; Vegh P; Berry L; Hoogendoorn H; Andrew M
Thromb Haemost; 1995 Sep; 74(3):859-63. PubMed ID: 8571311
[TBL] [Abstract][Full Text] [Related]
33. Serum immunoglobulin concentrations in preschool children measured by laser nephelometry: reference ranges for IgG, IgA, IgM.
Isaacs D; Altman DG; Tidmarsh CE; Valman HB; Webster AD
J Clin Pathol; 1983 Oct; 36(10):1193-6. PubMed ID: 6619317
[TBL] [Abstract][Full Text] [Related]
34. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
Hausser H; Kresse H
Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
[TBL] [Abstract][Full Text] [Related]
35. [A study on glycosaminoglycans in a case of pulmonary emphysema (author's transl)].
Masakichi M; Hideo A; Atsunobu Y; Hirosi S; Nagai H
Z Erkr Atmungsorgane; 1975 Jun; 143(3):270-6. PubMed ID: 132017
[TBL] [Abstract][Full Text] [Related]
36. The catabolism of intravenously injected heparan N-[35S] sulphate in the rat.
Perry MA; Powell GM; Wusteman FS; Curtis CG
Biochem J; 1977 Sep; 166(3):373-9. PubMed ID: 145856
[TBL] [Abstract][Full Text] [Related]
37. Excretion patterns of glycosaminoglycans and glycoproteins in normal human urine.
Manley G; Severn M; Hawksworth J
J Clin Pathol; 1968 May; 21(3):339-45. PubMed ID: 4235293
[TBL] [Abstract][Full Text] [Related]
38. Molecular distinctions between heparan sulphate and heparin. Analysis of sulphation patterns indicates that heparan sulphate and heparin are separate families of N-sulphated polysaccharides.
Gallagher JT; Walker A
Biochem J; 1985 Sep; 230(3):665-74. PubMed ID: 2933029
[TBL] [Abstract][Full Text] [Related]
39. Circulating glycosaminoglycan species in septic shock.
Nelson A; Berkestedt I; Bodelsson M
Acta Anaesthesiol Scand; 2014 Jan; 58(1):36-43. PubMed ID: 24341693
[TBL] [Abstract][Full Text] [Related]
40. Structure and metabolism of rat liver heparan sulphate.
Oldberg A; Höök M; Obrink B; Pertoft H; Rubin K
Biochem J; 1977 Apr; 164(1):75-81. PubMed ID: 141928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
